The 5th European Biosimilars Congress 2016 covers topics such as:
- Emerging Biosimilars in Therapeutics
- Challenges and Regulatory Approach for Biosimilars
- Emerging Biologics in Therapeutics
- Clinical Studies and Clinicians Prospects for Biosimilars
- Biosimilars Innovator Pharmaceutical Products
- Globalization of Biosimilars
- Bioequivalence Assessment
- Biosimilar Analytical Strategies
- Plant Produced Biosimilar Products
- BCS & IVIVC Based Biowaivers
- Regulatory Affairs and Intellectual Property Rights
- Pharmacovigilance and its Challenges
- Biosimilar Companies and Market Analysis
- Current Challenges in Advancement of Biologics
The 5th European Biosimilars Congress 2016 brings together senior attendees involved or interested in:
- Biosimilars
- Biologics
- Biobetters
- Biowaivers
- Biotechnology
